ATE241286T1 - Verwendung von t-tagatose als praebiotischen nahrungsmittelzusatz - Google Patents

Verwendung von t-tagatose als praebiotischen nahrungsmittelzusatz

Info

Publication number
ATE241286T1
ATE241286T1 AT99904733T AT99904733T ATE241286T1 AT E241286 T1 ATE241286 T1 AT E241286T1 AT 99904733 T AT99904733 T AT 99904733T AT 99904733 T AT99904733 T AT 99904733T AT E241286 T1 ATE241286 T1 AT E241286T1
Authority
AT
Austria
Prior art keywords
tagatose
preebiotic
food additive
food
stimulates
Prior art date
Application number
AT99904733T
Other languages
English (en)
Inventor
Mads Liendgaard Vigh
Henrik Andersen
Original Assignee
Arla Foods Amba
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arla Foods Amba filed Critical Arla Foods Amba
Application granted granted Critical
Publication of ATE241286T1 publication Critical patent/ATE241286T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/30—Artificial sweetening agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT99904733T 1998-02-24 1999-02-23 Verwendung von t-tagatose als praebiotischen nahrungsmittelzusatz ATE241286T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7569498P 1998-02-24 1998-02-24
PCT/DK1999/000074 WO1999043217A1 (en) 1998-02-24 1999-02-23 Use of d-tagatose as a prebiotic food component

Publications (1)

Publication Number Publication Date
ATE241286T1 true ATE241286T1 (de) 2003-06-15

Family

ID=22127401

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99904733T ATE241286T1 (de) 1998-02-24 1999-02-23 Verwendung von t-tagatose als praebiotischen nahrungsmittelzusatz

Country Status (12)

Country Link
EP (1) EP1056358B1 (de)
JP (1) JP2002504500A (de)
KR (1) KR100620477B1 (de)
AT (1) ATE241286T1 (de)
AU (1) AU742777B2 (de)
BR (1) BR9908221A (de)
DE (1) DE69908306T2 (de)
DK (1) DK1056358T3 (de)
ES (1) ES2198126T3 (de)
NO (1) NO316874B1 (de)
PT (1) PT1056358E (de)
WO (1) WO1999043217A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2315220T3 (es) * 2000-05-01 2009-04-01 Societe Des Produits Nestle S.A. Proceso de fabricacion de una barra de cereales.
US7189351B2 (en) * 2001-10-25 2007-03-13 Spherix Incorporated D-tagatose as an anti-biofilm agent
JP5749880B2 (ja) * 2008-05-27 2015-07-15 松谷化学工業株式会社 Ｄ−タガトースを有効成分とする体脂肪蓄積改善剤およびメタボリックシンドローム改善剤
KR101381794B1 (ko) 2012-04-10 2014-04-07 씨제이제일제당 (주) 타가토스 및 프로바이오틱 유산균을 함유하는 신바이오틱 식품 조성물
CN104780783A (zh) 2012-09-11 2015-07-15 西拉比索公司 益生元类囊体组合物
KR101632687B1 (ko) * 2013-01-14 2016-06-22 씨제이제일제당(주) 타가토스를 함유하는 저지방 아이스크림용 조성물, 이를 이용한 저지방 아이스크림, 및 그 제조 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4786722A (en) * 1986-08-29 1988-11-22 Biospherics Incorporated D-tagatose as a low-calorie carbohydrate sweetener and bulking agent
US5356879A (en) * 1992-02-14 1994-10-18 Biospherics, Incorporated D-tagatose as anti-hyperglycemic agent
JPH0665080A (ja) * 1992-03-10 1994-03-08 Godo Shiyusei Kk α−グルコシダ−ゼ阻害剤を含有する、過血糖付随疾患の予防・治療剤、および保健食

Also Published As

Publication number Publication date
KR20010034534A (ko) 2001-04-25
JP2002504500A (ja) 2002-02-12
DE69908306D1 (de) 2003-07-03
PT1056358E (pt) 2003-10-31
NO316874B1 (no) 2004-06-07
DE69908306T2 (de) 2003-11-27
DK1056358T3 (da) 2003-09-22
EP1056358A1 (de) 2000-12-06
ES2198126T3 (es) 2004-01-16
NO20004224D0 (no) 2000-08-23
AU2512699A (en) 1999-09-15
KR100620477B1 (ko) 2006-09-13
NO20004224L (no) 2000-10-23
BR9908221A (pt) 2000-10-24
WO1999043217A1 (en) 1999-09-02
EP1056358B1 (de) 2003-05-28
AU742777B2 (en) 2002-01-10

Similar Documents

Publication Publication Date Title
CY1107323T1 (el) Αναστολεις πρωτεασωμικης δρασης για διεγepση τριχοφυϊας
IT1299162B1 (it) Assieme protesico da impiegarsi nelle terapie chirurgiche del prolasso urogenitale
FI932290A0 (fi) Anvaendning av mesomorfa faser i matprodukter
BRPI0515227A (pt) cepa de lactobacillus rhamnosus, composição para produzir cla, processo para produção em massa de cla, alimento funcional com redução de corpo de gordura, produtos diários, alimentos fermentados e medicamento para prevenção e para tratamento de doenças relacionadas á obesidade
DK1455603T3 (da) Stimulering af in vivo produktion af proteiner med en formulering, der omfatter leucin
FI970747A (fi) Yhdistelmävalmiste käytettäväksi immunologisissa sairauksissa
MXPA06000441A (es) Derivado de 2-acilaminotiazole o sal del mismo.
MXPA02009794A (es) Composicion para promover el sueno-.
DE69813839D1 (de) Verwendung von n,n-bis (phenylcarbamoylmethyl) dimethylammoniumchlorid und derivaten davon zur behandlung von chronischem schmerz
TR200103819T2 (tr) kanser tedavisinde ET743 terkipleri ve kullanımları
ATE241286T1 (de) Verwendung von t-tagatose als praebiotischen nahrungsmittelzusatz
ATE289808T1 (de) Caroteinoid-nicotinamid-zink zusammensetzungen und verfahren zur behandlung unter verwendung derselben
IL150125A0 (en) Novel compounds
PL340467A1 (en) Application of mithrazapin in treating apnoea dissomnia
HUP0202730A2 (hu) Eljárás friss hús felületének kezelésére
DE60323529D1 (de) Rutheniumkomplexe mit antikrebswirkung
FR2704393B1 (fr) Complément nutritionnel absorbable pour optimiser la croissance et maintenir la solidité des os.
CA99898S (en) Filter for aquariums
DE69922174D1 (de) Biomaterial zur behandlung von zahnfäule
TR200003552T2 (tr) İnsan proteini C polipeptit.
MD1505G2 (ro) Preparat pentru tratamentul afecţiunilor reumatoide
GB0218926D0 (en) Improvements in and relating to the treatment of sunburn
RU99111444A (ru) Способ заместительной терапии у мужчин с возрастным андрогенным дефицитом
RU95104131A (ru) Целебная пищевая добавка
UA33291A (uk) Пристрій для лікування бджіл від аскосферозу

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1056358

Country of ref document: EP

REN Ceased due to non-payment of the annual fee